Guided Biofilm Therapy for Periodontal Patients.

February 18, 2024 updated by: Andrea Scribante, University of Pavia

Guided Biofilm Therapy for Periodontal Patients Using Two Different Devices: a Split-mouth Randomized Clinical Trial

Periodontal patients will be treated with Guided Biofilm Therapy. At the baseline (T0), the following clinical indices will be collected: BoP, BS, CAL, PPD. A plaque disclosing agents will be used to instruct the patients to proper oral hygiene procedures. At this stage, using a split-mouth design, quadrants will be randomized to:

  • Airflow and Scaling and calculus removal with EMS Prophylaxis Master handpiece
  • Airflow and calculus removal with Mectron Combi handpiece

Patients will be visited after 1 month (T1) and 2 months (T2), in which the periodontal indexes will be collected again.

After all the procedures, VAS for pain will be assessed, with Schiff Air Index, comfort (patients), comfort (operator), timing for the procedures (minutes), satisfaction questionnaire (for patients and for the operator), consumption of the powders for the two handpiece.

Study Overview

Detailed Description

Periodontal patients that respond to the inclusion criteria and agree to participate in the study will be treated with Guided Biofilm Therapy.

At the baseline (T0), the following clinical indices will be collected: BoP, BS, CAL, PPD. A plaque disclosing agents will be used to instruct the patients to proper oral hygiene procedures. At this stage, using a split-mouth design, quadrants will be randomized to:

  • Airflow and calculus removal with EMS Prophylaxis Master handpiece
  • Airflow and calculus removal with Mectron Combi handpiece

Patients will be visited after 1 month (T1) and 2 months (T2), in which the periodontal indexes will be collected again.

Together with periodontal assessment, VAS for pain will be assessed, with Schiff Air Index, comfort (patients), comfort (operator), timing for the procedures (minutes), satisfaction questionnaire (for patients and for the operator), consumption of the powders for the two handpieces.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lombardy
      • Pavia, Lombardy, Italy, 27100
        • Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • professional dental hygiene performed at least 6 months before enrollment
  • periodontal disease: grading A or B and staging I-III

Exclusion Criteria:

  • neurologic, psychiatric and mental diseases
  • patients taking antibiotics during the study
  • pregnant and breastfeeding women
  • patients undergoing anticancer treatment
  • patients undergoing anticancer therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Half of patients will be included in this group according to the split-mouth design.
  • Plaque disclosing agent application and instructions to patients for a correct oral hygiene;
  • Airflow deplaquing with EMS handpiece (quadrants Q2 and Q4) and with Mectron handpiece (quadrants Q1 and Q3)
  • Calculus removal with EMS ultrasound handpiece (Q2 and Q4) and with Mectron handpiece (Q1 and Q3)
Experimental: Group B
Half of patients will be included in this group according to the split-mouth design.
  • Plaque disclosing agent application and instructions to patients for a correct oral hygiene;
  • Airflow deplaquing with EMS handpiece (quadrants Q1 and Q3) and with Mectron handpiece (quadrants Q2 and Q4)
  • Calculus removal with EMS ultrasound handpiece (Q1 and Q3) and with Mectron handpiece (Q2 and Q4)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Schiff Air Index - Dental sensitivity test
Time Frame: Baseline, after 30 and 60 days

Scoring criteria:

0. the subject did not respond to air blasting;

  1. the subject responded to air blasting;
  2. the subject responded to air blasting and requested discontinuation;
  3. the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.
Baseline, after 30 and 60 days
Change in BOP - Bleeding on Probing (percentage)
Time Frame: Baseline, after 30 and 60 days
Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 4 sites (mesial, distal, vestibular, palatal/lingual).
Baseline, after 30 and 60 days
Change in Bleeding Score (BS - Mombelli et al.)
Time Frame: Baseline, after 30 and 60 days

Scoring criteria:

0: no bleeding

  1. isolated visible spots
  2. blood forms a confluent red line on the mucosal margin
  3. profuse and copious bleeding
Baseline, after 30 and 60 days
Change in Probing Pocket Depth (PPD)
Time Frame: Baseline, after 30 and 60 days
Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.
Baseline, after 30 and 60 days
Change in CAL - Clinical Attachment Loss
Time Frame: Baseline, after 30 and 60 days
Measurement (in mm) of the position of the gingival margin in relation to the cemento-enamel junction (CEJ).
Baseline, after 30 and 60 days
Total time of usage
Time Frame: Baseline
Total time of usage of the two handpieces.
Baseline
Comfort for the operator
Time Frame: Baseline
Evaluation of the comfort of the operator from 0 to 10 during professional procedures.
Baseline
Satisfactory questionnaire for patients
Time Frame: Baseline

Choice of a score from 0 to 10 for all the following questions:

  • Is the time for the procedures appropriate?
  • Is the quantity of droplets adequate?
  • Dental sensitivity
  • Pain with the first instrument
  • Pain with the second instrument
  • General pain
Baseline
Satisfactory questionnaire for operator
Time Frame: Baseline
Comfort (from 0 to 10) Timing (from 0 to 10)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Scribante, DDS, PhD, MS, University of Pavia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 22, 2022

Primary Completion (Actual)

August 29, 2022

Study Completion (Actual)

September 2, 2022

Study Registration Dates

First Submitted

February 20, 2022

First Submitted That Met QC Criteria

February 21, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 18, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-GBT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on Split-mouth administration for group A

3
Subscribe